Search
Exact matches only
Search in title
Search in content
Search in comments
Search in excerpt
Search in posts
Search in pages
Search in groups
Search in users
Search in forums
Filter by Custom Post Type
Filter by Categories
Filter by Report Categories
Advance Interior Materials
Agriculture Industry
Agrochemicals & fertilizers
Animal feed and feed additives
Automotive Sector
Automotive & Transportation
Biotechnology
Building & Construction
Building & Construction Materials
Electronics & Semiconductors
Electronic Devices
Electronic Security
Energy & Resources
Alternative Energy
Distribution & Utilities
Power generation and storage
Food & Beverage
Food Additives and Nutricosmetics
Life Sciences
Healthcare
Wellness
Personal Care & Cosmetics
Materials & Chemicals
Advanced Materials
Advanced Materials (Green Building Materials)
Ceramic & Fiber
Coatings & printing inks
Organic Chemicals
Paints
Petrochemicals
Plastics
Polymers & Resins
Renewable Chemicals
Specialty & Fine Chemicals
Specialty glass
Specialty Polymer
Medical Devices
Pharmaceuticals
Clinic Diagnostics
Technology & Media
Communication Infrastructure
Communication Services
HVAC and Construction
Next Generation Technologies
Textiles
Smart Textiles
{ "homeurl": "https://www.marketresearchandstatistics.com/", "resultstype": "vertical", "resultsposition": "hover", "itemscount": 4, "imagewidth": 70, "imageheight": 70, "resultitemheight": "auto", "showauthor": 0, "showdate": 0, "showdescription": 1, "charcount": 3, "noresultstext": "No results!", "didyoumeantext": "Did you mean:", "defaultImage": "https://www.marketresearchandstatistics.com/wp-content/plugins/ajax-search-pro/img/default.jpg", "highlight": 0, "highlightwholewords": 1, "openToBlank": 0, "scrollToResults": 0, "resultareaclickable": 1, "autocomplete": { "enabled": 1, "googleOnly": 0, "lang": "en" }, "triggerontype": 1, "triggeronclick": 1, "triggeronreturn": 1, "triggerOnFacetChange": 0, "overridewpdefault": 0, "redirectonclick": 1, "redirectClickTo": "results_page", "redirect_on_enter": 1, "redirectEnterTo": "results_page", "redirect_url": "?s={phrase}", "more_redirect_url": "?s={phrase}", "settingsimagepos": "left", "settingsVisible": 0, "hresulthidedesc": "0", "prescontainerheight": "400px", "pshowsubtitle": "0", "pshowdesc": "1", "closeOnDocClick": 1, "iifNoImage": "description", "iiRows": 2, "iiGutter": 5, "iitemsWidth": 200, "iitemsHeight": 200, "iishowOverlay": 1, "iiblurOverlay": 1, "iihideContent": 1, "loaderLocation": "auto", "analytics": 0, "analyticsString": "", "aapl": { "on_click": 0, "on_magnifier": 0, "on_enter": 0, "on_typing": 0 }, "compact": { "enabled": 0, "width": "100%", "closeOnMagnifier": 1, "closeOnDocument": 0, "position": "static", "overlay": 0 }, "animations": { "pc": { "settings": { "anim" : "fadedrop", "dur" : 300 }, "results" : { "anim" : "fadedrop", "dur" : 300 }, "items" : "fadeInDown" }, "mob": { "settings": { "anim" : "fadedrop", "dur" : 300 }, "results" : { "anim" : "fadedrop", "dur" : 300 }, "items" : "voidanim" } }, "autop": { "state": "disabled", "phrase": "", "count": 10 } }

Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H1, 2016

$2,500

This report provides top line data relating to the clinical trials on Herpes Labialis (Oral Herpes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. …..

Total Pages: 60

herpes-labialis-oral-herpes-global-clinical-trials-review-h1-2016
600
#9e2f22

GlobalData's clinical trial report, “Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H1, 2016" provides an overview of Herpes Labialis (Oral Herpes) clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Labialis (Oral Herpes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials 27
Prominent Drugs 29
Clinical Trial Profile Snapshots 30
Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 58
About GlobalData 59
Contact Us 59
Disclaimer 59
Source 60

List of Tables
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Region, 2016* 6
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14
Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 15
Herpes Labialis (Oral Herpes) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
Herpes Labialis (Oral Herpes) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 18
Herpes Labialis (Oral Herpes) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Herpes Labialis (Oral Herpes) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List of Figures
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 13
Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 15
Herpes Labialis (Oral Herpes) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
Herpes Labialis (Oral Herpes) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 18
Herpes Labialis (Oral Herpes) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Herpes Labialis (Oral Herpes) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
GlobalData Methodology 58


LICENSE TYPE